Acquisitions and agreements keep Verfora ahead

24 January 2022 - Deborah Wilkes

Acquisitions and new in-licensing agreements helped lift sales at Galenica’s Products & Brands business – which mainly consists of the Verfora consumer healthcare unit – by 17.8% to CHF132 million (USD142 million) in 2021.